Thus, the majority of mAbs that recognize EpCAM on cancer cells bind specifically to the EpCL domain (amino acids 24–80) of EpCAM (Fig. 1a), and that region is considered to offer high immunogenicity12,17. The gene discussed is EPCAM; the disease is cancer.